FDA.govCoronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure ...Dec 8, 2021bookmark_bordersharemore_vert
ReutersU.S. FDA authorizes use of AstraZeneca COVID-19 antibody cocktailDec 8, 2021bookmark_bordersharemore_vert
Business WireEVUSHELD (formerly AZD7442) long-acting antibody combination authorized for emergency use in the US for pre ...Dec 8, 2021bookmark_bordersharemore_vert
NBC NewsFDA clears AstraZeneca's Covid antibody treatment for immunocompromisedDec 8, 2021Benjamin RyanBy Benjamin Ryanbookmark_bordersharemore_vert